According to one or more embodiments, cationic polymers may be produced which include one or more monomers containing cations. Such cationic polymers may be utilized as structure directing agents to for mesoporous zeolites. The mesoporous zeolites may include micropores as well as mesopores, and may have a surface area of greater than 350 m.sup.2/g and a pore volume of greater than 0.3 cm.sup.3/g. Also described are core/shell zeolites, where at least the shell portion includes a mesoporous zeolite material.

According to one or more embodiments, cationic polymers may be produced which include one or more monomers containing cations. Such cationic polymers may be utilized as structure directing agents to for mesoporous zeolites. The mesoporous zeolites may include micropores as well as mesopores, and may have a surface area of greater than 350 m.sup.2/g and a pore volume of greater than 0.3 cm.sup.3/g. Also described are core/shell zeolites, where at least the shell portion includes a mesoporous zeolite material.

According to one or more embodiments, cationic polymers may be produced which include one or more monomers containing cations. Such cationic polymers may be utilized as structure directing agents to for mesoporous zeolites. The mesoporous zeolites may include micropores as well as mesopores, and may have a surface area of greater than 350 m.sup.2/g and a pore volume of greater than 0.3 cm.sup.3/g. Also described are core/shell zeolites, where at least the shell portion includes a mesoporous zeolite material.

According to one or more embodiments, cationic polymers may be produced which include one or more monomers containing cations. Such cationic polymers may be utilized as structure directing agents to for mesoporous zeolites. The mesoporous zeolites may include micropores as well as mesopores, and may have a surface area of greater than 350 m.sup.2/g and a pore volume of greater than 0.3 cm.sup.3/g. Also described are core/shell zeolites, where at least the shell portion includes a mesoporous zeolite material.

The present disclosure relates to a process for producing a mono-alkylated aromatic compound using a treated catalyst made by a method of this invention is disclosed. The method comprises the steps of heating an untreated catalyst in the presence of a gaseous stream having a dew point temperature less than about 5 C. to form a treated catalyst. The treatment is effective to improve the activity and selectivity of the catalyst.

A catalytic additive comprising an intermediate pore zeolite, such as ZSM-5 is treated so as to improve propylene yields when the additive is included in a FCC catalytic inventory by first treating the zeolite with a phosphorus compound to incorporate the phosphorus in the zeolite, and mixing the P-treated zeolite with a matrix component comprising kaolin and another phosphorus-containing compound.

The present invention relates to an SCR-active material, comprising a small-pore zeolite, aluminum oxide and copper, characterized in that it contains 5 to 25 wt-% of aluminum oxide in relation to the entire material and that the copper is present on the aluminum oxide in a first concentration and on the small-pore zeolite in a second concentration.

A process for the calcination of a zeolitic material, wherein the process contains the steps of (i) providing a zeolitic material containing YO.sub.2 and optionally further containing X.sub.2O.sub.3 in its framework structure in the form of a powder and/or of a suspension of the zeolitic material in a liquid, wherein Y stands for a tetravalent element and X stands for a trivalent element; (ii) atomization of the powder and/or of the suspension of the zeolitic material provided in (i) in a gas stream for obtaining an aerosol; and (iii) calcination of the aerosol obtained in (ii) for obtaining a calcined powder, a zeolitic material obtained by the above process, and its use as a molecular sieve, as an adsorbent for ion-exchange, as a catalyst, and/or as a catalyst support.

A nanotherapeutic supported by a hierarchical silica composite with dual imaging capability (e.g. fluorescence and magnetic resonance imaging), a method of preparing the nanotherapeutic, and a method of treating cancer. Also disclosed is a method of oxidatively dehydrogenating ethane using a catalytic system supported by a hierarchical silica composite.

According to one or more embodiments, a mesoporous zeolite may included a microporous framework that includes a plurality of micropores having diameters of less than or equal to 2 nm, and a plurality of mesopores having diameters of greater than 2 nm and less than or equal to 50 nm. The mesoporous zeolite may included an aluminosilicate material, a titanosilicate material, or a pure silicate material. The mesoporous zeolite may included a surface area of greater than 350 m.sup.2/g and a pore volume of greater than 0.3 cm.sup.3/g.